Lipid and Metabolite Deregulation in the Breast Tissue of Women CarryingBRCA1andBRCA2Genetic Mutations
Authors:
- Saadallah RamadanSRSaadallah Ramadan
- Jameen ArmJAJameen Arm
- Judith SilcockJSJudith Silcock
- Gorane SantamariaGSGorane Santamaria
- Jessica BuckJBJessica Buck
- Michele RoyMRMichele Roy
- Kin Men LeongKLKin Men Leong
- Peter LauPLPeter Lau
- David ClarkDCDavid Clark
- Peter MalychaPMPeter Malycha
- Carolyn MountfordCMCarolyn Mountford
- 1 June 2015
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 275 (3) , 675-682
Abstract
To use localized correlated spectroscopy (COSY) to assess for an altered biochemical state or states in breast tissue of women with BRCA gene mutations that potentially constitute preinvasive conditions. Institutional review board approval was obtained. Participants provided written informed consent. In vivo localized COSY images were recorded at 3 T in the breast tissue of women carrying BRCA1 (n = 9) or BRCA2 (n = 14) gene mutations and were compared with images in healthy control subjects with no family history of breast cancer (n = 10). All participants underwent contrast material-enhanced MR imaging and ultrasonography (US). Statistical significance was calculated with the Mann-Whitney two-sided nonparametric test. No abnormality was recorded with MR imaging or US. Metabolite levels in the BRCA1 cohort were reduced by 79% (P = .014) when compared with triglycerides level, and there was a 19% increase in lipid unsaturation and triglyceride levels (P = .027 and P = .086, respectively) when compared with cellular cholesterol level. Cholesterol level was reduced by 47% (P = .027) when compared with diallylic lipid level. Metabolite levels in the BRCA2 cohort showed increased unsaturation of 21% (P = .030) relative to triglycerides level. Comparison of the BRCA1 and BRCA2 cohorts showed a 47% (P = .002) increase in cholesterol level in the BRCA2 cohort when compared with diallylic lipid level and a 52% (P = .003) increase when compared with triglycerides level. Levels of diallylic lipid, unsaturated lipid, triglycerides, and terminal methyl on the acyl chain are reduced by 46% (P = .002), 57% (P = .003), 66% (P = .003), and 29% (P = .010), respectively, when compared with cholesterol level. Localized COSY recorded significant changes in women with BRCA1 and BRCA2 gene mutations when compared with control subjects. If these changes are ultimately proven to be a premalignant stage, this method may prove useful in screening.Keywords
This publication has 23 references indexed in Scilit:
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- Use of in Vivo Two-dimensional MR Spectroscopy to Compare the Biochemistry of the Human Brain to That of GlioblastomaRadiology, 2011
- Investigation of breast cancer using two‐dimensional MRSNMR in Biomedicine, 2009
- Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRIEuropean Radiology, 2008
- Proton spectroscopy provides accurate pathology on biopsy and in vivoJournal of Magnetic Resonance Imaging, 2006
- Proton MRS Can Determine the Pathology of Human Cancers with a High Level of AccuracyChemical Reviews, 2004
- Localized two‐dimensional shift correlated MR spectroscopy of human brainMagnetic Resonance in Medicine, 2001
- Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopyInternational Journal of Cancer, 1994
- Malignancy-related characteristics of wild type and drug-resistant chinese hamster ovary cellsPathology, 1993
- Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cellsEuropean Journal of Biochemistry, 1992